ZAHRAVI PHARMACEUTICAL COMPANY

Shahid Beheshti Street No.178, Western Hoveysh Street, Tehran, Iran

Also known as:

dzah 1

Clinical Trials

5 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Not Applicable

80.0%

Phase 3

20.0%

Trial Status Distribution

Not yet recruiting

100.0%

Clinical Trials

Trials sponsored by this organization (5)

Study of absorption and elimination rate of Dutasteride capsules 0.5 mg in comparison with Dutasteride brand capsules (Avodart ®).

Study of absorption and elimination rate of Fampridine 10-mg tablet in comparison with Fampridine brand tablet (Fampyra®).

Study of absorption and elimination rate of Fingolimod 0.5-mg capsule in comparison with Fingolimod brand Capsule (Gilenya®).

Bioequivalence study of Teriflunomide 14 mg tablets produced by Zahravi Pharmaceutical Co. versus Aubagio® tablets of Sanofi Genzyme Co. in 14 healthy male under fasting conditions

Effect of Dinvl on improving of clinical and paraclinical symptoms in patients with COVID-19

Approvals

No approval data available

News

No news articles found

Back to Organizations